Key statistics
On Monday, Veracyte Inc (12V:BER) closed at 23.00, 21.05% above the 52 week low of 19.00 set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.00 |
---|---|
High | 23.00 |
Low | 23.00 |
Bid | 22.80 |
Offer | 23.20 |
Previous close | 22.80 |
Average volume | 7.14 |
---|---|
Shares outstanding | 78.31m |
Free float | 76.90m |
P/E (TTM) | 65.36 |
Market cap | 2.14bn USD |
EPS (TTM) | 0.4189 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 07:00 BST.
More ▼
- Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
- Veracyte to Participate in Upcoming Investor Conferences
- Veracyte Announces First Quarter 2025 Financial Results
- Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
- Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
- Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
- Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
More ▼